Varicella Seroprevalence Among Turkish Medical Students and the Validity of Disease History
To the Editor:
Varicella is the leading cause of vaccine-preventable death among children in the developed world. Adults with a definite history of chickenpox are usually immune, 1 and 71% to 93% of adult patients without a definite history of varicella are also seropositive. 27 A serologic test may thus be cost-effective for determining varicella zoster virus (VZV) immunity in adults with a negative history prior to immunization against varicella. On the contrary, children without a clear history of varicella have seroprevalence rates ranging from 9% to 68% depending on age and clinical history. 8 An intermediate prevalence may sometimes be found in young adult populations, which have a greater risk than young children for developing serious complications such as pneumonia and encephalitis. 9 Medical students have a high risk of exposure to varicella in pediatric clinics, especially in areas where varicella immunization is not routine as it is now in much of the world.
Susceptible medical students are thus at increased risk for infection and, if infected, can expose susceptible patients at high risk.
1011 Airborne nosocomial transmission of VZV has occurred without direct contact with the index patient. 12 Screening medical students with a negative history for varicella antibody can determine susceptibility. 4 
"
6 This study sought to determine varicella seroprevalence among medical students.
Preclinical medical students (class 3), 20 to 23 years of age, were recruited in 1998 from the Hacettepe University Faculty of Medicine. Verbal informed consent was obtained from all subjects. Students were excluded if they had a history of previous vaccination or if they had had immunosuppressive therapy, blood products, or immunoglobulins within 3 months before enrollment.
A questionnaire was administered regarding history of varicella and serologic samples were drawn for antibody to VZV. Serum samples were stored at -20° C until IgG antibodies were assayed. A commercial kit was used (Serion ELISA classic VaricellaZoster-Virus IgG Lot VAR.3, Serion Immundiagnostica GmbH, Wiirzburg, Germany). The assay thresholds were less than 60 mlU/mL for seronegative, 60 to 80 mlU/mL for equivocal, and greater than 80 mlU/mL for seropositive.
Statistical analysis was performed using SPSS software (SPSS, Inc., Chicago, IL) for Windows 7.5 (Microsoft Corp., Redmond, WA). Geometric mean titers and 95% confidence intervals (CI 95 ) were calculated. Histories of varicella infection were compared with the seropositivity to determine sensitivity, specificity, and positive and negative predictive values.
Mean age was 21.3 ± 0.8 years. Males comprised 41.3% of the study group. One hundred eighty (98.3%) of the students were immune and 4 (2.2%) were seronegative. None of the students had been vaccinated. The geometric mean titer of seropositive cases was 1,182 mlU/mL (CI 95 ,1,056 to 1,323 mlU/mL). There was no difference between male and female students regarding geometric mean titer.
Overall, 104 students (56.5%) said that they had had varicella. All students with a positive history were seropositive (positive predictive value, 100%). Of the students with negative or unknown histories, only 4 were seronegative (negative predictive value, 5.0%). History had 57.8% sensitivity and 100% specificity. Students with positive histories had higher geometric mean titers (1,378 mlU/mL; CI 95 , 1,197 to 1,586 mlU/mL) than did those with negative histories (959 mlU/mL; CI 95 , 802 to 1,146 mlU/mL) (P = .002; Table) .
This study found that 2.2% of the medical students at Hacettepe University Faculty of Medicine lacked immunity to VZV, results comparable to those of other studies of adults. It has been suggested that immunity levels of 94% or more are needed to interrupt virus transmission. 114 VZV infection is not rare among medical students of Hacettepe University (one to two cases per year). This results in loss of academic time for the student, potential transmission to patients, and sometimes closure of a ward to control varicella transmission. GMT -geometric mean titer; CI95 -95% confidence interval. V-.0O2.
Overall, 56.5% of the students indicated that they had a positive history of varicella, but only 5.0% were determined to be susceptible. These data support other reports that describe negative histories of varicella as being unreliable.
27 Screening hospital personnel with negative histories for varicella antibodies, when applicable, may assist in identifying susceptible individuals. Because approximately 70% to 90% of adults without a history of varicella will be immune, it should be cost-effective to perform serologic tests and immunize the few who are seronegative. Healthcare workers, including medical students, who do not have a history of varicella should be tested serologically, and those who are seronegative and without a contraindication should be immunized. 1 ' 14 Not every hospital has a policy for VZV control. No employee screening program for varicella has existed in this institution, but immunosuppressed patients are frequentiy admitted to various wards throughout the hospital. Screening personnel with a negative or uncertain history of varicella is likely to be cost-effective because a varicella serologic test costs $14 (U.S. dollars), most individuals are immune, and a dose of varicella vaccine costs $55 to $60 (U.S. dollars) in Turkey. Medical students should be included in this protocol. R E F E R E N C E S 
